New Data Demonstrates DIFICLIR(TM) May Offer Benefits for Cancer Patients, who ... MarketWatch (press release) Clostridium difficile Infection in Cancer Patients and Hematopoietic Stem Cell Transplant Recipients. Expert Rev Anti Infect Ther. 2010; 8 (10): 1113-1119. 6. Cornely A, et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in ... |
